These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 15006917

  • 1. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
    Le Marchand L, Haiman CA, van den Berg D, Wilkens LR, Kolonel LN, Henderson BE.
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
    [Abstract] [Full Text] [Related]

  • 2. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B.
    Cancer Res; 2005 Apr 15; 65(8):3454-61. PubMed ID: 15833881
    [Abstract] [Full Text] [Related]

  • 3. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.
    Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE.
    Cancer Epidemiol Biomarkers Prev; 2004 Dec 15; 13(12):2071-7. PubMed ID: 15598763
    [Abstract] [Full Text] [Related]

  • 4. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A, Shu XO, Cai Q, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun 15; 14(6):1567-70. PubMed ID: 15941974
    [Abstract] [Full Text] [Related]

  • 5. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study.
    Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR.
    Cancer Epidemiol Biomarkers Prev; 2005 Aug 15; 14(8):1998-2003. PubMed ID: 16103451
    [Abstract] [Full Text] [Related]

  • 6. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study.
    Le Marchand L, Wilkens LR, Kolonel LN, Henderson BE.
    Cancer Epidemiol Biomarkers Prev; 2005 May 15; 14(5):1198-203. PubMed ID: 15894672
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk.
    Lee KM, Park SK, Hamajima N, Tajima K, Yoo KY, Shin A, Noh DY, Ahn SH, Hirvonen A, Kang D.
    Breast Cancer Res Treat; 2005 Mar 15; 90(2):149-55. PubMed ID: 15803361
    [Abstract] [Full Text] [Related]

  • 8. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
    Li Z, Habuchi T, Tsuchiya N, Mitsumori K, Wang L, Ohyama C, Sato K, Kamoto T, Ogawa O, Kato T.
    Carcinogenesis; 2004 Feb 15; 25(2):237-40. PubMed ID: 14604900
    [Abstract] [Full Text] [Related]

  • 9. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
    Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, Chen J.
    Breast Cancer Res Treat; 2010 Oct 15; 123(3):857-61. PubMed ID: 20157775
    [Abstract] [Full Text] [Related]

  • 10. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
    Haiman CA, Stram DO, Cheng I, Giorgi EE, Pooler L, Penney K, Le Marchand L, Henderson BE, Freedman ML.
    Cancer Epidemiol Biomarkers Prev; 2006 May 15; 15(5):1021-5. PubMed ID: 16702386
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2427-32. PubMed ID: 16046504
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidity.
    González-Zuloeta Ladd AM, Arias-Vásquez A, Siemes C, Coebergh JW, Hofman A, Witteman J, Uitterlinden A, Stricker BH, van Duijn CM.
    Eur J Cancer; 2007 Jan 15; 43(2):371-4. PubMed ID: 17035001
    [Abstract] [Full Text] [Related]

  • 16. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort.
    Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE.
    Cancer Res; 2003 Oct 15; 63(20):6984-7. PubMed ID: 14583500
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival.
    Zheng W.
    Methods Mol Biol; 2009 Oct 15; 472():265-77. PubMed ID: 19107437
    [Abstract] [Full Text] [Related]

  • 18. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
    Wei YS, Xu QQ, Wang CF, Pan Y, Liang F, Long XK.
    Tissue Antigens; 2007 Dec 15; 70(6):464-9. PubMed ID: 17990985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.